Onward Opportunities Stock Quote ONWD - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

122.50

Bid

121.00

Ask

124.00

Volume

0.00

122.50 Day's Range 122.50

101.00 52 Week Range 124.50

Market Cap

21.508M

Previous Close

122.50

Open

122.50

Last Trade

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

35,478

Shares Outstanding

17,557,378

Dividend Yield

PE Ratio

14.03

Earnings Per Share (EPS)

0.09

Revenue

1.99M

Net Profit

1.53M

Sector

Trust,ex Ed,religious,charty

Industry

Trust,ex Ed,religious,charty

Website

www.onwardopportunities.co.uk

Headquarters

Guernsey, Gbr

Founded

1970

Onward Opportunities Limited is listed in the Trust,ex Ed,religious,charty sector of the London Stock Exchange with ticker ONWD. The last closing price for Onward Opportunities was 122.50p. Over the last year, Onward Opportunities shares have traded in a share price range of 101.00p to 124.50p.

Onward Opportunities currently has 17,557,378 shares outstanding. The market capitalization of Onward Opportunities is £21.51 million. Onward Opportunities has a price to earnings ratio (PE ratio) of 14.03.

Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx™ System for Administration of nusinersen

Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx™ System for Administration of nusinersen PR Newswire LOWELL...

New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer’s Disease Patients Presented at The Alzheimer’s Association International Conference (AAIC

51% of No Tau / Low Tau Patients Showed Improved Cognition and Function Over Three Years; Only Lecanemab Has Clinical Data in No Tau / Low Tau Patient Group Clinical Data and Biomarkers Show...

New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer's Disease Patients Presented at The Alzheimer's Association International Conference (AAIC) 20

New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer's Disease Patients Presented at...

Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease

The collaboration aims to identify and develop accessible, minimally invasive blood-based biomarkers specific for tau pathology in the brainThese tools have the potential to be used to stratify...

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

TOKYO and CAMBRIDGE, Mass., July 26, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge...

Sage Therapeutics and Biogen Announce Topline Results from Phase 2 KINETIC 2 Study of SAGE-324 (BIIB124) for the Treatment of Essential Tremor

- SAGE-324 (BIIB124) did not demonstrate a statistically significant dose-response relationship on the primary endpoint in participants with essential tremor - No statistically significant...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	122.5	122.5	122.5	1000	122.5	DE
4	-1	-0.80971659919	123.5	123.5	121.5	90204	122.49722727	DE
12	7.5	6.52173913043	115	124.5	114.5	35478	122.02847026	DE
26	21.5	21.2871287129	101	124.5	101	31917	115.36918753	DE
52	17	16.1137440758	105.5	124.5	101	36755	108.32165278	DE
156	26	26.9430051813	96.5	124.5	96.5	43266	107.05905427	DE
260	26	26.9430051813	96.5	124.5	96.5	43266	107.05905427	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
JWNGJaywing Plc	3.00p (114.29%)	3.1M
ECHOEcho Energy Plc	0.0041p (28.13%)	18.1B
MTROMetro Bank Holdings Plc	51.10p (27.11%)	15.52M
STXShield Therapeutics Plc	2.40p (20.00%)	7.4M
CRSCrystal Amber Fund Limited	108.00p (20.00%)	38.71k
UKOGUk Oil & Gas Plc	0.06p (-21.05%)	2.67B
MCONMincon Group Plc	35.00p (-18.60%)	172.2k
NARFNarf Industries Plc	0.90p (-18.18%)	19.53M
TUNTungsten West Plc	2.25p (-18.18%)	419.34k
BIRDBlackbird Plc	6.25p (-16.67%)	877.17k
ECHOEcho Energy Plc	0.0041p (28.13%)	18.1B
UKOGUk Oil & Gas Plc	0.06p (-21.05%)	2.67B
MSMNMosman Oil And Gas Limited	0.047p (-16.07%)	1.05B
VELAVela Technologies Plc	0.0095p (11.76%)	465.07M
GWMOGreat Western Mining Corporation Plc	0.0465p (-3.13%)	387.62M